Audited Consolidated Statements of Operations - USD ($)	12 Months Ended
	Aug. 31, 2022	Aug. 31, 2021
Operating expenses:
Research and development expense	$ 1,183,281	$ 1,771,533
General and administrative expenses	1,770,689	828,644
Total operating expenses	2,953,970	2,600,177
Loss from operations	(2,953,970)	(2,600,177)
Other income
Capital Gain	12,800	195,968
Financial (loss) income, net	(782,080)	(790,238)
Net (loss) income	(3,723,250)	(3,194,447)
(Loss) Profit from available for sale assets	(669,131)	868,696
Total comprehensive (loss) income	$ (4,392,381)	$ (2,325,751)